from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3747/-

LFCtreatmentdescriptionclass of inhibitor

0.455

Amikacinug/mL Amikacintranslation

0.842

Cap5-10ug/mL Capreomycintranslation

1.572

Rox10-50 ug/mL Roxithromycintranslation

0.709

SM2-5 ug/mL Streptomycintranslation

0.523

Tet5-10 ug/mL Tetracyclinetranslation

-1.080

Rif0.2-5ug/mL Rifampicintranscription

0.097

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.663

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.929

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.873

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.336

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.211

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.650

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.475

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.085

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.071

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.392

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.357

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.531

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.595

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.979

KCN5-20 ug/mL Potassium cyaniderespiration

-0.266

NaN30.2-2 mM Sodium aziderespiration

1.095

Nigericin50 uM Nigericinrespiration

-0.441

TRC10-150 ug/mL Triclosanrespiration

-1.974

TRZ10-25 ug/mL Thioridazinerespiration

-0.483

Valinomycin0.5-10 uM Valinomycinrespiration

1.382

ZnSO42 mM ZnSO4respiration

0.350

menadione6-10 ug/mL Menadionerespiration

-0.452

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.872

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.149

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.124

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.431

NRP_1Non-replicating persistence stage 1dosRassociated

0.683

Amp0.2mg/mL AmpicillincellWall

0.562

Cephalexin20-100 ug/mL CephalexincellWall

0.687

Cerulenin0.32-5 ug/mL CerulenincellWall

0.781

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.659

EMB10-20 ug/mL EthambutolcellWall

0.920

Eta12-40 ug/mL EthionamidecellWall

1.069

INH0.2-0.4 ug/mL IsoniazidcellWall

0.292

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.681

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.693

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.194

BZA0.12 mg/mL BenzamidearomaticAmides

0.041

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.476

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.231

H2O24 mM hydrogen peroxideDNAdamaging

0.160

Levo10 ug/mL LevofloxacinDNAdamaging

0.475

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.876

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.960

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.804

UVUV-irradiationDNAdamaging

-1.008

ARP41-4 ug/mL Antitubercular compound ARP4?

0.447

Antimycin12.5-50 ug/mL Antimycin A?

0.863

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.274

PA_110-50 ug/mL Antitubercular compound PA-1?

0.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.724

PA8240.2-2 ug/mL PA-824?

-0.726

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.228

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.067

Verapamil50 uM Verapamil?

0.497

mercaptoethanol2 mM 2-Mercaptoethanol?

0.837

methoxatin10-20 ug/mL Methoxatin?